These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
378 related articles for article (PubMed ID: 22484770)
1. Cochlea radiation dose correlates with hearing loss after stereotactic radiosurgery of vestibular schwannoma. Hayden Gephart MG; Hansasuta A; Balise RR; Choi C; Sakamoto GT; Venteicher AS; Soltys SG; Gibbs IC; Harsh GR; Adler JR; Chang SD World Neurosurg; 2013; 80(3-4):359-63. PubMed ID: 22484770 [TBL] [Abstract][Full Text] [Related]
2. Significance of cochlear dose in the radiosurgical treatment of vestibular schwannoma: controversies and unanswered questions. Jacob JT; Carlson ML; Schiefer TK; Pollock BE; Driscoll CL; Link MJ Neurosurgery; 2014 May; 74(5):466-74; discussion 474. PubMed ID: 24476904 [TBL] [Abstract][Full Text] [Related]
3. Progression of hearing loss after LINAC-based stereotactic radiotherapy for vestibular schwannoma is associated with cochlear dose, not with pre-treatment hearing level. van Linge A; van Os R; Hoekstra N; Heijmen B; Stienstra L; Dallenga A; Wolbers J; Mendez Romero A Radiat Oncol; 2018 Dec; 13(1):253. PubMed ID: 30583739 [TBL] [Abstract][Full Text] [Related]
6. Chasing the Holy Grail of vestibular schwannoma management. Link MJ; Pollock BE World Neurosurg; 2013; 80(3-4):276-8. PubMed ID: 22705754 [No Abstract] [Full Text] [Related]
8. Stereotactic radiosurgery for vestibular schwannomas: average 10-year follow-up results focusing on long-term hearing preservation. Watanabe S; Yamamoto M; Kawabe T; Koiso T; Yamamoto T; Matsumura A; Kasuya H J Neurosurg; 2016 Dec; 125(Suppl 1):64-72. PubMed ID: 27903183 [TBL] [Abstract][Full Text] [Related]
9. Increased cochlear radiation dose predicts delayed hearing loss following both stereotactic radiosurgery and fractionated stereotactic radiotherapy for vestibular schwannoma. Patel KS; Ng E; Kaur T; Miao T; Kaprealian T; Lee P; Pouratian N; Selch MT; De Salles AAF; Gopen Q; Tenn S; Yang I J Neurooncol; 2019 Nov; 145(2):329-337. PubMed ID: 31552587 [TBL] [Abstract][Full Text] [Related]
10. Preserved Cochlear CISS Signal is a Predictor for Hearing Preservation in Patients Treated for Vestibular Schwannoma With Stereotactic Radiosurgery. Prabhu V; Kondziolka D; Hill TC; Benjamin CG; Shinseki MS; Golfinos JG; Roland JT; Fatterpekar GM Otol Neurotol; 2018 Jun; 39(5):628-631. PubMed ID: 29561382 [TBL] [Abstract][Full Text] [Related]
11. Gamma knife radiosurgery for vestibular schwannoma: early hearing outcomes and evaluation of the cochlear dose. Lasak JM; Klish D; Kryzer TC; Hearn C; Gorecki JP; Rine GP Otol Neurotol; 2008 Dec; 29(8):1179-86. PubMed ID: 18931646 [TBL] [Abstract][Full Text] [Related]
12. Hearing Outcomes After Stereotactic Radiosurgery for Vestibular Schwannomas : Mechanism of Hearing Loss and How to Preserve Hearing. Han JH; Kim DG; Chung HT; Paek SH; Jung HW Adv Tech Stand Neurosurg; 2016; (43):3-36. PubMed ID: 26508404 [TBL] [Abstract][Full Text] [Related]
13. Predictors of hearing loss after gamma knife radiosurgery for vestibular schwannomas: age, cochlear dose, and tumor coverage. Brown M; Ruckenstein M; Bigelow D; Judy K; Wilson V; Alonso-Basanta M; Lee JY Neurosurgery; 2011 Sep; 69(3):605-13; discussion 613-4. PubMed ID: 21471832 [TBL] [Abstract][Full Text] [Related]
14. A comprehensive analysis of hearing preservation after radiosurgery for vestibular schwannoma. Yang I; Sughrue ME; Han SJ; Aranda D; Pitts LH; Cheung SW; Parsa AT J Neurosurg; 2010 Apr; 112(4):851-9. PubMed ID: 19747043 [TBL] [Abstract][Full Text] [Related]
15. Radiosurgery of vestibular schwannoma: prognostic factors for hearing outcome using 3D-constructive interference in steady state (3D-CISS). Wagner F; Gandalini M; Hakim A; Ermis E; Leiser D; Zbinden M; Anschuetz L; Raabe A; Caversaccio M; Wiest R; Herrmann E Strahlenther Onkol; 2018 Dec; 194(12):1132-1143. PubMed ID: 30203112 [TBL] [Abstract][Full Text] [Related]
16. Long-term hearing outcomes following stereotactic radiosurgery for vestibular schwannoma: patterns of hearing loss and variables influencing audiometric decline. Carlson ML; Jacob JT; Pollock BE; Neff BA; Tombers NM; Driscoll CL; Link MJ J Neurosurg; 2013 Mar; 118(3):579-87. PubMed ID: 23101446 [TBL] [Abstract][Full Text] [Related]
17. Congress of Neurological Surgeons Systematic Review and Evidence-Based Guidelines on Hearing Preservation Outcomes in Patients With Sporadic Vestibular Schwannomas. Carlson ML; Vivas EX; McCracken DJ; Sweeney AD; Neff BA; Shepard NT; Olson JJ Neurosurgery; 2018 Feb; 82(2):E35-E39. PubMed ID: 29309683 [TBL] [Abstract][Full Text] [Related]
19. Gamma knife radiosurgery for vestibular schwannomas: results of hearing preservation in relation to the cochlear radiation dose. Timmer FC; Hanssens PE; van Haren AE; Mulder JJ; Cremers CW; Beynon AJ; van Overbeeke JJ; Graamans K Laryngoscope; 2009 Jun; 119(6):1076-81. PubMed ID: 19399836 [TBL] [Abstract][Full Text] [Related]
20. Hearing outcomes after stereotactic radiosurgery for unilateral intracanalicular vestibular schwannomas: implication of transient volume expansion. Kim YH; Kim DG; Han JH; Chung HT; Kim IK; Song SW; Park JH; Kim JW; Kim YH; Park CK; Kim CY; Paek SH; Jung HW Int J Radiat Oncol Biol Phys; 2013 Jan; 85(1):61-7. PubMed ID: 22580122 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]